COOHIGH SIGNALFINANCIAL10-K

Cooper Companies achieved extraordinary revenue growth of 284% to $2.5B, representing a transformational expansion in business scale.

This massive revenue increase suggests either a major acquisition, significant organic growth breakthrough, or fundamental business model expansion that wasn't clearly disclosed in the language changes. The proportional increases in interest expense (+84%) and accounts receivable (+16%) support legitimate business growth rather than accounting irregularities, though the magnitude warrants careful investor scrutiny of the underlying drivers.

Comparing 2025-12-05 vs 2024-12-06View on EDGAR →
FINANCIAL ANALYSIS

Cooper Companies experienced explosive growth with revenue surging 284% to $2.5B while maintaining strong operational fundamentals, as evidenced by operating cash flow growing 12% to $796M and R&D investment increasing 11% to $172M. Interest expense doubled to $105M, likely reflecting debt financing to support this dramatic expansion, while accounts receivable grew a more modest 16% to $829M. The overall financial picture suggests a major transformational event—likely a significant acquisition—that dramatically expanded the company's scale while preserving operational efficiency and cash generation capabilities.

FINANCIAL STATEMENT CHANGES
Revenue
P&L
+283.8%
$660.0M$2.5B

Strong top-line growth of 283.8% — accelerating demand or successful expansion into new markets.

Interest Expense
P&L
+83.8%
$57.3M$105.3M

Interest expense surged 83.8% — significant debt increase or rising rates materially impacting earnings.

Accounts Receivable
Balance Sheet
+15.6%
$717.0M$829.0M

Receivables grew 15.6% — monitor days sales outstanding for collection efficiency.

Operating Cash Flow
Cash Flow
+12.2%
$709.3M$796.1M

Operating cash flow grew 12.2% — strong conversion of earnings to cash, healthy business fundamentals.

R&D Expense
P&L
+11%
$155.1M$172.2M

R&D investment increased 11% — signals commitment to future product development, though near-term margin impact.

LANGUAGE CHANGES
NEW — 2025-12-05
PRIOR — 2024-12-06
ADDED
Management's Discussion and Analysis of Financial Condition and Results of Operations 46 Item 7A.
The actual imposition or threats of tariffs, customs duties and fees by the U.S.
government and other nations in response and other retaliatory actions, such as trade protection measures, import or export licensing requirements, new or different customs duties, trade embargoes and sanctions and other trade barriers, as well as the impact of the Company s efforts to mitigate the effects of such tariffs or similar measures.
(Cooper, we or the Company), is a leading global medical device company focused on helping people experience life's beautiful moments.
Headquartered in San Ramon, California, Cooper sells products in over 130 countries and positively impacts over fifty million lives each year.
+7 more — sign up free →
REMOVED
Management's Discussion and Analysis of Financial Condition and Results of Operations 45 Item 7A.
(Cooper, we or the Company), is a global medical device company with a mission to improve lives one person at a time.
We partner with health care providers worldwide to improve patient outcomes and deliver practice-building resources and training.
By listening closely to the healthcare providers and patients, we fulfill the needs of today while focusing on the opportunities of tomorrow through innovation and strategic investment.
In November 2019, the MiSight 1 day lens became the first and only product approved by the United States Food and Drug Administration (FDA) for slowing the progression of myopia in children aged 8-12 at the initiation of treatment, and in August 2021, CooperVision received Chinese National Medical Products Administration (NMPA) approval for use of the MiSight 1 day lens in China.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →